Dose number | Time (min) | #Amount (units/ml) | ml | Units | Cumulative dose in units |
---|---|---|---|---|---|
1 | 0 | 1000 | 0·1 | 100 | 100 |
2 | 15 | 1000 | 0·2 | 200 | 300 |
3 | 30 | 1000 | 0·4 | 400 | 700 |
4 | 45 | 1000 | 0·8 | 800 | 1500 |
5 | 60 | 1000 | 1·6 | 1600 | 3100 |
6 | 75 | 1000 | 3·2 | 3200 | 6300 |
7 | 90 | 1000 | 6·4 | 6400 | 12 700 |
8 | 105 | 10 000 | 1·2 | 12 000 | 24 700 |
9 | 120 | 10 000 | 2·4 | 24 000 | 48 700 |
10 | 135 | 10 000 | 4·8 | 48 000 | 96 700 |
11 | 150 | 80 000 | 1 | 80 000 | 176 700 |
12 | 165 | 80 000 | 2 | 160 000 | 336 700 |
13 | 180 | 80 000 | 4 | 320 000 | 656 700 |
14 | 195 | 80 000 | 8 | 640 000 | 1 296 700 |
15 | 225 | Parenteral (intravenous) penicillin is given, after which regular doses should be administered for the duration of treatment. Benzathine penicillin (intramuscular) can be given after step 14. Further doses are usually given every 1–3-weekly but a test dose with penicillin V (400 000 U) is given prior to administration of each dose of benzathine penicillin including the first dose after step 14, patient is observed for an hour before administration of benzathine penicillin and further monitoring in hospital overnight is required |
Adapted from Wendel et al. [104]. #This treatment must be delivered in an intensive care or high dependency unit. +Obtain informed consent, check pulse, blood pressure and peak expiratory flow rate and repeat prior to every step. Also, monitor patient for signs and symptoms of allergic reaction.